Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Heron Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Heron Therapeutics

Heron Therapeutics

Public

Heron Therapeutics: A US-based biotech firm enhancing injectable pharmaceuticals via proprietary drug delivery tech.

HQ
San Diego, CA, US
Founded
1983
Overview
Compare
Fundraising
Employees
Website

Heron Therapeutics, founded in Redwood City, United States, is a biotechnology company dedicated to enhancing the therapeutic profiles of injectable pharmaceuticals through its proprietary biochronomer drug delivery technology. The company's core mission is to improve patient outcomes by reformulating existing therapies to provide better efficacy and safety. Heron Therapeutics focuses on developing best-in-class medicines that significantly improve the quality of life for patients.

Notable figures associated with Heron Therapeutics include its leadership team and board members who bring extensive experience in biotechnology and pharmaceuticals. The company has garnered significant investment from prominent biotech investors. Key achievements include the FDA approval of their products Aponvie™ and Zynrelef®, which have set new standards in post-surgical pain management. Heron Therapeutics' innovative approach has had a substantial impact on the biotech industry, particularly in the realm of drug delivery systems.

Heron Therapeutics - Similar Companies

Hera Health Solutions logo

Hera Health Solutions

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Theron Pharmaceuticals logo

Theron Pharmaceuticals

Xeris Biopharma Holdings logo

Xeris Biopharma Holdings

Halozyme Therapeutics logo

Halozyme Therapeutics

halozyme.com

Chromis Therapeutics logo

Chromis Therapeutics

Cytonus Therapeutics logo

Cytonus Therapeutics

cytonus.com

Durect logo

Durect

durect.com

Teon Therapeutics logo

Teon Therapeutics

Bluejay Therapeutics logo

Bluejay Therapeutics

bluejaytx.com

Hengrui Therapeutics logo

Hengrui Therapeutics

Therabron Therapeutics logo

Therabron Therapeutics

therabron.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Eton Pharmaceuticals logo

Eton Pharmaceuticals

United Therapeutics logo

United Therapeutics

Heron Therapeutics - Quick Facts

Who are Heron Therapeutics' competitors?

Companies similar to Heron Therapeutics include Hera Health Solutions, Eikon Therapeutics, Theron Pharmaceuticals and Xeris Biopharma Holdings.

When was Heron Therapeutics founded?

Heron Therapeutics was founded in 1983.

Where is Heron Therapeutics' headquarters located?

Heron Therapeutics' headquarters is located in San Diego, CA, US.

When was Heron Therapeutics' last funding round?

Heron Therapeutics' most recent funding round was for $30M (USD) in July 2023.

How much has Heron Therapeutics raised to-date?

As of Jul 24, 2023, Heron Therapeutics has raised a total of $974M (USD).

How many employees does Heron Therapeutics have?

Heron Therapeutics has 203 employees as of Feb 6, 2024.

Heron Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
Unique IDs
  • secCik: 0000818033
  • ticker: HRTX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 24 more industry codes
NAICS
  • 320000Manufacturing
  • 325200Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing
  • 325210Resin and Synthetic Rubber Manufacturing
  • 325211Plastics Material and Resin Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325600Soap, Cleaning Compound, and Toilet Preparation Manufacturing
  • 325620Toilet Preparation Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2820Plastics Materials And Synthetic Resins, Synthetic Rubber, Cellulosic Manmade Fibers
  • 2821Plastics Materials, Synthetic Resins, And Nonvulcanizable Elastomers
  • 2844Perfumes, Cosmetics, And Other Toilet Preparations
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 2013Manufacture of plastics and synthetic rubber in primary forms
  • 2023Manufacture of soap and detergents, cleaning and polishing preparations, perfumes and toilet preparations